Research Needs to Improve Hypertension Treatment and Control in African Americans.

Hypertension

From the Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine (P.K.W., K.C.F.), and Department of Medicine, Tulane University School of Medicine (P.K.W., K.C.F.), New Orleans, LA; Division of Cardiovascular Sciences (P.T.E., P.D.-N., G.A.M., J.A.C.), and Center for Translation Research and Implementation Science (N.G., G.A.M.), National Heart, Lung, and Blood Institute, Bethesda, MD; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham (P.M.); Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD (L.J.A., L.A.C., E.R.M.); Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, TN (W.C.C.); Department of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, PA (A.V.D.R.); Department of Medicine, Case Western Reserve University, University Hospitals Case Medical Center, Louis Stokes Cleveland VA Medical Center, OH (M.R., J.T.W.); Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA (H.A.T.); Department of Epidemiology and Prevention (J.A.) and Department of Medicine (B.I.F., J.A.), Wake Forest School of Medicine, Wake Forest University, Winston Salem, NC; Dean's Office, University of Kentucky College of Public Health, Lexington (D.K.A.); Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City (B.L.C.); Department of Biostatistics, University of Texas School of Public Health, Houston (B.R.D.); Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL (R.C.); Division of Research, Kaiser Permanente Northern California, Oakland (A.S.G.); Department of Internal Medicine, Baylor College of Medicine, Houston, TX (D.J.H.); National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (P.L.K.); HealthPartners Institute, Minneapolis, MN (K.L.M.); Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.M.N.); Department of Population Health, NYU School of Medicine, New York (G.O.); American Medical Association, Chicago, IL (M.K.R.); Department of Nephrology and Hypertension, Cleveland Clinic, OH (G.T.); Clinical Directors Network (CND) and The Rockefeller University Center for Clinical and Translational Science, New York (J.N.T.); and National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD (S.S.(S.)Y.).

Published: November 2016

Additional targeted research and customized training programs could spearhead strategies for elimination of the disparities in prevalence and control of high BP between African Americans and the remainder of the US general population.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063700	PMC
http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07905	DOI Listing

Publication Analysis

Top Keywords

african americans

improve hypertension

hypertension treatment

treatment control

control african

americans additional

additional targeted

targeted customized

customized training

training programs

Similar Publications

Norman B. Anderson (1955-2024).

Am Psychol

January 2025

Florida State University.

James J Clark

Memorializes Norman B. Anderson (1924-2024). Norman B.

View Article and Find Full Text PDF

Similar Publications

Cross-Sectional Comparison of Structural MRI Markers of Impairment in a Diverse Cohort of Older Adults.

Hum Brain Mapp

February 2025

Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.

Julie K Wisch Kalen Petersen Peter R Millar Omar Abdelmoity Ganesh M Babulal

Neurodegeneration is presumed to be the pathological process measure most proximal to clinical symptom onset in Alzheimer Disease (AD). Structural MRI is routinely collected in research and clinical trial settings. Several quantitative MRI-based measures of atrophy have been proposed, but their low correspondence with each other has been previously documented.

View Article and Find Full Text PDF

Similar Publications

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans.

Clin Pharmacol Ther

January 2025

Department of Pharmacology, Center for Pharmacogenomics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Guang Yang Cristina Alarcon Catherine Chanfreau Norman H Lee Paula Friedman

Clopidogrel, an anti-platelet drug, is used to prevent thrombosis after percutaneous coronary intervention. Clopidogrel resistance results in recurring ischemic events, with African Americans (AA) suffering disproportionately. The aim of this study was to discover novel biomarkers of clopidogrel resistance in African Americans using genome and transcriptome data.

View Article and Find Full Text PDF

Similar Publications

Understanding Types of Stigma Experienced in Black Women Living With HIV in Baltimore, Maryland: A Mixed Methods Study.

Nurs Open

January 2025

Johns Hopkins University School of Nursing, Baltimore, Maryland, USA.

Tanya Mikhael Kyra Jennifer Waligora Mendez Chun-An Sun Joy Chepkorir Hae-Ra Han

Aim: To understand how Black or African American women living with HIV (WLH) experience different types of stigma in their daily lives.

Design: Secondary analysis of quantitative and qualitative data from a recent clinical trial in Baltimore, Maryland.

Methods: Quantitative data were collected in the baseline survey, and qualitative data were gathered during 6-month follow-up focus group and individual interviews.

View Article and Find Full Text PDF

Similar Publications

HIV service use among minoritized racial and ethnic transgender and gender non-conforming youth in the U.S South: a qualitative investigation.

AIDS Care

January 2025

Westat, Rockville, MD, USA.

Linda J Koenig Deborah Gelaude Yuko Mizuno Pilgrim Spikes Jarvis Carter

Transgender youth are disproportionately affected by HIV, particularly minoritized youth in the US south. To understand HIV service use among transgender youth, we interviewed 25 young racial and ethnic minority clients of four southern community-based HIV service organizations (CBOs), and CBO staff ( = 12), about service access and use. Participants were assigned male at birth and identified as female ( = 8), transgender ( = 11) or gender-fluid or nonbinary ( = 6).

View Article and Find Full Text PDF

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!